Secret Disease Meeting Announced With Maximum Transparency: None
Published Date: 1/15/2025
Notice
Summary
The National Institute of Allergy and Infectious Diseases is holding a closed meeting on February 12, 2025, to review important grant applications for clinical trials. This meeting affects researchers seeking funding for allergy and infectious disease studies and keeps sensitive information private. The decisions made could impact future research funding and medical breakthroughs.
Free Policy Watch
New rules are filed every week. Most people never see them.
Pick a topic. PRIA watches every federal rule and tells you when one hits your household.
Pick a topic to get started
Analyzed Economic Effects
2 provisions identified: 1 benefits, 0 costs, 1 mixed.
NIAID clinical trial grant review
If you are a researcher applying for clinical-trial grants, NIAID will review and evaluate those applications on February 12, 2025 from 11:00 a.m. to 2:00 p.m. The panel will consider Investigator-Initiated Extended Clinical Trial (R01, Clinical Trial Required) and NIAID Clinical Trial Implementation Cooperative Agreement (U01, Clinical Trial Required) applications, which can affect who receives research funding.
Meeting closed to protect confidentiality
The meeting on February 12, 2025 will be closed to the public under 5 U.S.C. 552b(c)(4) and 552b(c)(6). The closure is to protect confidential trade secrets or commercial property (such as patentable material) and personal information about people associated with the grant applications.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Take It Personal
Get Your Personalized Policy View
Take the PRIA Score to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in